Prevalence and Incidence of HCV Infection among Vietnam Heroin Users with Recent Onset of Injection

被引:0
作者
Michael C. Clatts
Vivian Colón-López
Le M. Giang
Lloyd A. Goldsamt
机构
[1] University of Puerto Rico,School of Public Health
[2] Hanoi Medical University,Center for Research and Training on HIV/AIDS
[3] National Development and Research Institutes,Center for Research on Global Health, Graduate School of Public Health
[4] Inc.,undefined
[5] University of Puerto Rico,undefined
[6] Medical Sciences Campus,undefined
来源
Journal of Urban Health | 2010年 / 87卷
关键词
Hepatitis C prevalence; HCV incidence; Onset and initiation of heroin injection; IDU's; Harm reduction; Vietnam;
D O I
暂无
中图分类号
学科分类号
摘要
HCV infection continues to spread at an alarming rate among IDU populations. The available evidence suggests that HCV is acquired relatively quickly following onset of injection. However, there are few prospective studies of HCV acquisition, particularly among IDU populations in resource-poor settings. A sample of young male heroin injectors with recent onset of injection (<4 years) was recruited in Hanoi, Vietnam for a prospective assessment of the early course of injection (n = 179). Both behavioral and biological assessments (including detailed retrospective assessment of injection initiation) were conducted at baseline and repeated at 6-month intervals for a period of 16 months. Variables associated with HCV infection (p value < 0.05) in bivariate analyses were considered for inclusion in logistic regression models to identify risk factors independently associated with HCV infection. HCV incidence was calculated by using the incidence density approach and was expressed in terms of person-years of observation. The baseline of prevalence of HCV was 46%. HCV significantly increased in relation to time since first injection, from 30% in subjects with ≤10 months of injection risk to 70% in subjects with ≥30 months injection risk (p value = 0.0005). In multivariate logistic regression analysis, increasing age, incarceration in a drug detention facility (OR = 2.54; 95%CI 1.05, 6.15), and time since first injection remained significantly associated with HCV infection. Use of injection as primary mode of administration (OR = 2.56; 95%CI 0.98, 6.69) achieved marginal significance. After 16 months of follow-up, the incidence rate of HCV was 23.35 per 100 person-years and the mean time between first injection and first positive HCV test was 1.2 years. HCV is acquired much more rapidly among new injector populations than previously recognized, demonstrating the need for early behavioral intervention among new heroin-user populations. Particularly critical are interventions that target new heroin user populations, including interventions that improve understanding of viral transmission dynamics, that promote alternative strategies for drug sharing, and that delay initiation of injection.
引用
收藏
页码:278 / 291
页数:13
相关论文
共 89 条
  • [11] Monterroso E(2005)Drug and sexual risk in four men who have sex with men populations: evidence for a sustained HIV epidemic in New York City J Urban Health 82 i9-i17
  • [12] Brown D(2007)Novel heroin injection practices: implications for transmission of HIV and other bloodborne pathogens Am J Prev Med 32 S226-S233
  • [13] Vlahov D(2001)Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco Hepatology 34 180-187
  • [14] Garfein RS(2002)Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users Hepatology 36 737-742
  • [15] Vlahov D(2000)Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997–1999 J Infect Dis 182 1588-1594
  • [16] Galai N(1998)Prevalence and incidence of hepatitis C virus infection among young adult injection drug users J Acquir Immune Defic Syndr Hum Retrovirol 18 S11-S19
  • [17] Doherty MC(2004)HIV and hepatitis C coinfection within the CAESAR study HIV Med 5 174-179
  • [18] Nelson KE(2003)The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy J Acquir Immune Defic Syndr 33 365-372
  • [19] Hagan H(2000)Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study Lancet 356 1800-1805
  • [20] Thiede H(1999)Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study J Viral Hepat 6 53-57